Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alexandre Belot

Showing results (161-170 of 250) with videos related to

Pageof 25
Sort By:
Infectious Diseases and Therapy|July 10, 2021
Refining "Long-COVID" by a Prospective Multimodal Evaluation of Patients with Long-Term Symptoms Attributed to SARS-CoV-2 InfectionMarc Scherlinger, Renaud Felten, Floriane Gallais, et al.
Revue Du Rhumatisme (Ed. Francaise : 1993)|October 4, 2021
Ludovic Trefond, Elodie Drumez, Marc Andre, et al.
The Lancet. Rheumatology|March 29, 2025
CAR T-cell therapy in autoimmune diseases: where are we and where are we going?Marc Scherlinger, Gaetane Nocturne, Marko Radic, et al.
Seminars in Arthritis and Rheumatism|September 27, 2021
DADA2 diagnosed in adulthood versus childhood: A comparative study on 306 patients including a systematic literature review and 12 French casesAntoine Fayand, François Chasset, David Boutboul, et al.
Molecular Psychiatry|February 7, 2023
Early systemic inflammation induces neurodevelopmental disorders: results from ARTEMIS, a French multicenter study of juvenile rheumatisms and systemic autoimmune and auto-inflammatory disorders and meta-analysisPierre Ellul, Isabelle Melki, Stephanie Antoun, et al.
Joint Bone Spine|May 29, 2021
Impact of hydroxychloroquine used as DMARD on SARS-CoV-2 tests and infection evolution in a population of 871 patients with inflammatory rheumatic and musculoskeletal diseasesLudovic Trefond, Elodie Drumez, Marc Andre, et al.
Joint Bone Spine|September 12, 2018
Safety of biological agents in paediatric rheumatic diseases: A real-life multicenter retrospective study using the JIRcohorte databaseNatalia Cabrera, Jean-Christophe Lega, Behrouz Kassai, et al.
Arthritis Care & Research|January 29, 2023
Patient-Reported Outcomes Among Patients Ages Two to Seventeen Years With Polyarticular-Course Juvenile Idiopathic Arthritis Treated With Subcutaneous Abatacept: Two-Year Results From an International Phase III StudyNicolino Ruperto, Daniel J Lovell, Alberto Berman, et al.
Orphanet Journal of Rare Diseases|December 30, 2025
Prevalence estimation of a rare disease with the French National Rare Disease Registry: example of TNF receptor associated periodic syndrome (TRAPS)Adrien Subervie, Inès Elhani, Mathilde Labouret, et al.
Pediatric Nephrology (Berlin, Germany)|January 9, 2023
Pediatric ANCA vasculitis: clinical presentation, treatment, and outcomes in a French retrospective studySarah-Louisa Mahi, Siamak Bahram, Jérôme Harambat, et al.
Pageof 25

Showing results (161-170 of 250) with videos related to

Sort By:
Pageof 25
Infectious Diseases and Therapy|July 10, 2021
Refining "Long-COVID" by a Prospective Multimodal Evaluation of Patients with Long-Term Symptoms Attributed to SARS-CoV-2 InfectionMarc Scherlinger, Renaud Felten, Floriane Gallais, et al.
Revue Du Rhumatisme (Ed. Francaise : 1993)|October 4, 2021
Ludovic Trefond, Elodie Drumez, Marc Andre, et al.
The Lancet. Rheumatology|March 29, 2025
CAR T-cell therapy in autoimmune diseases: where are we and where are we going?Marc Scherlinger, Gaetane Nocturne, Marko Radic, et al.
Seminars in Arthritis and Rheumatism|September 27, 2021
DADA2 diagnosed in adulthood versus childhood: A comparative study on 306 patients including a systematic literature review and 12 French casesAntoine Fayand, François Chasset, David Boutboul, et al.
Molecular Psychiatry|February 7, 2023
Early systemic inflammation induces neurodevelopmental disorders: results from ARTEMIS, a French multicenter study of juvenile rheumatisms and systemic autoimmune and auto-inflammatory disorders and meta-analysisPierre Ellul, Isabelle Melki, Stephanie Antoun, et al.
Joint Bone Spine|May 29, 2021
Impact of hydroxychloroquine used as DMARD on SARS-CoV-2 tests and infection evolution in a population of 871 patients with inflammatory rheumatic and musculoskeletal diseasesLudovic Trefond, Elodie Drumez, Marc Andre, et al.
Joint Bone Spine|September 12, 2018
Safety of biological agents in paediatric rheumatic diseases: A real-life multicenter retrospective study using the JIRcohorte databaseNatalia Cabrera, Jean-Christophe Lega, Behrouz Kassai, et al.
Arthritis Care & Research|January 29, 2023
Patient-Reported Outcomes Among Patients Ages Two to Seventeen Years With Polyarticular-Course Juvenile Idiopathic Arthritis Treated With Subcutaneous Abatacept: Two-Year Results From an International Phase III StudyNicolino Ruperto, Daniel J Lovell, Alberto Berman, et al.
Orphanet Journal of Rare Diseases|December 30, 2025
Prevalence estimation of a rare disease with the French National Rare Disease Registry: example of TNF receptor associated periodic syndrome (TRAPS)Adrien Subervie, Inès Elhani, Mathilde Labouret, et al.
Pediatric Nephrology (Berlin, Germany)|January 9, 2023
Pediatric ANCA vasculitis: clinical presentation, treatment, and outcomes in a French retrospective studySarah-Louisa Mahi, Siamak Bahram, Jérôme Harambat, et al.
Pageof 25